Changes in mRNA expression levels of (A) uncoupling protein 1 (Ucp1), (B) Cidea, (C) PR-domain containing 16 (Prdm16), (D) PPAR-γ co-activator 1-alpha (Pgc1-α), (E) Glut4, and (F) type 2 iodothyronine deiodinase (Dio2) in periovarian (visceral) and lumbar (subcutaneous) adipose compartments in atherogenic diet-fed foz/foz mice vs. Wt, with or without OCA treatment. Data are mean ± SEM (n=9-10/gp). *P<0.05 vs. genotype-matched control (treatment effect), δP<0.05 vs. treatment-matched control (genotype effect).